Revenue: The sum of all revenue fields included for a company's operating activities.
Arrowhead Pharmaceuticals, Inc. (ARWR) had Revenue of $256.47M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$256.47M |
$-23.75M |
|
-- |
|
$256.47M |
|
$212.37M |
|
$44.11M |
|
$-7.99M |
|
$36.12M |
|
$36.12M |
|
$16.12M |
|
$16.12M |
|
$16.12M |
|
$16.12M |
|
$44.11M |
|
$49.25M |
|
133.76M |
|
133.76M |
|
$-0.14 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$950.64M |
|
$382.51M |
|
$434.66M |
|
$1.39B |
|
$195.49M |
|
$214.88M |
|
$686.39M |
|
$881.88M |
|
$503.42M |
|
$496.56M |
|
$503.42M |
|
135.70M |
|
| Cash Flow Statement Financials | |
$179.55M |
|
$-129.29M |
|
$74.01M |
|
$102.69M |
|
$226.55M |
|
$123.86M |
|
$63.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.86 |
|
-- |
|
-- |
|
0.30 |
|
0.51 |
|
100.00% |
|
17.20% |
|
17.20% |
|
-- |
|
14.08% |
|
-9.26% |
|
$156.89M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
-- |
|
37.58 |
|
2.39 |
|
3.20% |
|
3.25% |
|
1.16% |
|
2.24% |
|
$3.71 |
|
$1.17 |
|
$1.34 |
|